Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.150
-0.020 (-1.71%)
At close: Jun 5, 2026, 4:00 PM EDT
1.143
-0.007 (-0.60%)
After-hours: Jun 5, 2026, 7:36 PM EDT
Pliant Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
49
Market Cap
71.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.58M | -8.11M | -83.69% |
| Dec 31, 2022 | 9.69M | 2.11M | 27.91% |
| Dec 31, 2021 | 7.57M | -34.25M | -81.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Champions Oncology | 57.95M |
| Alterity Therapeutics | 4.43M |
| BeyondSpring | 1.88M |
| Seres Therapeutics | 1.15M |
| MediciNova | 596.64K |
PLRX News
- 15 days ago - Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 17 days ago - Pliant Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Pliant Therapeutics reports Q1 EPS (32c), consensus (36c) - TheFly
- 25 days ago - Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 25 days ago - Pliant Therapeutics Earnings release: Q1 2026 - Filings
- 25 days ago - Pliant Therapeutics Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Pliant Therapeutics doses first participant in FORTIFY expansion trial - TheFly